We are a privately held asset management company that invests in early-stage life science companies.
«There is no discovery without risk and what you risk reveals what you value.»
—Jeanette Winterson
Discoveries and innovations in healthcare have the potential to transform patients’ lives. Yet they also involve considerable risk of failing.
As early-stage investors, we aim to support breakthrough innovations. We value the opportunity to partner with entrepreneurs as they endeavor to take their innovations to the next level. When doing this, we appreciate not only the potential of innovations but also their underlying risks.
